We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ALTHX (MC $9 M) Alzheimer & Parkinson readout imminent
ALTHX.PA 7.700-2.0%Sep 24 4:00 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext  
From: BioHero12/13/2019 2:07:19 AM
   of 2
GREAT News out ...this is the cheapest stock i ever have seen before ,this could be a 10 bagger and more easily if everything goes well .Phase 1b readout of the Alzheimer trial expected before year end this could push this extrem low float rocket to new highs ...

Theranexus and Beyond Batten Disease Foundation (BBDF) announce the signing of a worldwide exclusive license for Batten disease drug candidate BBDF-101

The agreement covers the development and marketing of the drug following a single clinical trial due to begin in 2020.

If successful, this trial could lead directly to the drug's approval.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext